Edit search
Adalimumab and methotrextrate combination therapy in patient…
Adalimumab and methotrextrate combination therapy in patients with early RA sustains clinical remission and response through 5 years of adalimumab treatment.
Adalimumab and methotrextrate combination therapy in patients with early RA sustains clinical remission and response through 5 years of adalimumab treatment.
Article, Chapter
Authors: Pangan
Publication: Rheumatology, Volume:48, Issue:2, Page(s):119-119
ISSN: 1462-0324
  Full text availability for this item
Browse related articles
  Print copies at your library
  Request a copy of this item
Cite this item